- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
June 7, 2023Partner Tim Billion Honored With 2023 Appellate Advocacy Award
June 6, 2023Super Lawyers Names Five Attorneys to “Southern California Rising Stars” List
June 1, 2023Chambers USA Recognizes Five Robins Kaplan Practice Groups and 17 Lawyers in 2023 Guide
June 13, 20232023 Probate and Trust Law Section Conference
June 14, 2023Leading Through Uncertainty
June 15, 2023Enhance Your Super Powers by Clerking
May 2023Raoul Shah: Keeping Humanity and Compassion Close
May 18, 2023NFT Trademark Defense Comes Down To Licensing Terms
April 20, 2023Drafting Subsequent Agreements to Avoid Arbitrability Litigation
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Jake Holdreith Named Minnesota Litigator of the Year by Managing IP
April 28, 2023
Robins Kaplan LLP is pleased to announce that Jake Holdreith has been named 2023 “Minnesota Litigator of the Year” by Managing IP in its 18th annual awards. Additionally, Robins Kaplan was shortlisted for “Firm of the Year” in the following categories: Life Sciences IP Litigation (U.S. National), Patent Disputes (Midwest), and Trademark Disputes (Midwest).
According to Managing IP, its annual awards are presented to firms, individuals, and companies behind the most innovative and challenging intellectual property work of the past year, as well as those driving the international IP market.
Jake Holdreith leads the firm’s Health and Life Sciences Industry Group and serves as a member of the Executive Board. He is a known strategist and skilled courtroom lawyer who has tried jury cases to multi-million-dollar verdicts and has resolved complex cases at all stages of litigation. In 2022, he led a trial team representing University of Pennsylvania in a patent infringement action against Eli Lilly and ImClone related to the treatment of certain cancers with Erbitux, and represented Bioeq AG with resapect to certain IP matters for licensing Biologics License Application Number 761165 for a biosimilar to CIMERLI™ (ranibizumab-eqrn).
He also served as court-appointed co-lead trial counsel leading a trial team that achieved settlements in excess of $118 million on behalf of U.S. contact lens purchasers in an expansive antitrust class action against the four dominant manufacturers and the largest nationwide distributor of contact lenses.
Holdreith has been recognized for his achievements and leadership skills by multiple publications. In 2022 alone, he was named “Hatch-Waxman Litigator of the Year” by LMG Life Sciences, selected to the “IAM Strategy 300 Global Leaders Guide,” named a “Litigation Star” by Benchmark Litigation, received the “Patent Impact Case of the Year” award from LMG Life Sciences, and named an “Attorney of the Year” by The Best Lawyers in America.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.